Clinical Trial Update: A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a subject-tailored maintenance dosing approach for ustekinumab in adults with moderate-to-severe plaque psoriasis. Results fro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen Biotech, Inc. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2016-11-07